This article is more than 5 years old. Information may no longer be current.

LensAR femtosecond laser receives clearance for lens fragmentation, anterior capsulotomy

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ORLANDO, Fla. — The LensAR laser system has received 510(k) clearance from the U.S. Food and Drug Administration for lens fragmentation and anterior capsulotomy, the company announced in a press release.

The LensAR system increases precision during refractive cataract surgery using 3-D confocal structured illumination, a proprietary imaging and biometry system that analyzes the anatomy of the cataractous eye. The laser can fragment high-grade cataracts for easier removal and create an exact capsulotomy incision for IOL placement, the release said.

"Receiving the additional FDA indication for lens fragmentation is a significant milestone achievement in getting our technology one step closer to commercialization. We are very pleased with the exceptional fragmentation data that was submitted to obtain the indication and the resulting FDA clearance," Randy Frey, founder and CEO of LensAR, said in the release.